Dynamic Resurfacing SPF 30 10 mg/g
AVOBENZONE, OCTINOXATE, and OCTOCRYLENE · CREAM · ELEMIS Limited
Dynamic Resurfacing SPF 30 is a cream containing avobenzone, octinoxate, and octocrylene at 10 mg/g, taken topical. Manufactured by ELEMIS Limited.
Key Facts
- Brand Name
- Dynamic Resurfacing SPF 30
- Generic Name
- AVOBENZONE, OCTINOXATE, and OCTOCRYLENE
- NDC Code (Product)
65912-002- Manufacturer
- ELEMIS Limited
- Strength
- 10 mg/g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Application #
- M020
- Marketing Start
- 03/05/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Dynamic Resurfacing SPF 30 used for?
Dynamic Resurfacing SPF 30 contains AVOBENZONE, OCTINOXATE, and OCTOCRYLENE. It is a cream taken topical. Consult your doctor for specific uses.
Is Dynamic Resurfacing SPF 30 a controlled substance?
Dynamic Resurfacing SPF 30 is not classified as a controlled substance by the DEA.
What is the generic name for Dynamic Resurfacing SPF 30?
The generic name for Dynamic Resurfacing SPF 30 is AVOBENZONE, OCTINOXATE, and OCTOCRYLENE. There are 11 other brand versions of AVOBENZONE, OCTINOXATE, and OCTOCRYLENE.
What is the NDC code for Dynamic Resurfacing SPF 30 10 mg/g?
The NDC (National Drug Code) for Dynamic Resurfacing SPF 30 10 mg/g is 65912-002, listed by ELEMIS Limited.
Other Avobenzone, Brands
See all →- SHISEIDO BENEFIANCE WRINKLERESIST24 DAY1.94 g/75mL58411-628
- cle de peau BEAUTE SYNACTIF DAYTIME MOISTURIZER ENRICHED n5 mg/200mL58411-889
- SHISEIDO REVITALESSENCE SKIN GLOW PRIMER.77925 g/30mL58411-894
- cle de peau BEAUTE LONG-LASTING HYDRATING VEIL.795 g/30mL58411-623
- Pro-Collagen Marine Broad Spectrum SPF 3010 mg/g65912-001
- SHISEIDO BENEFIANCE NUTRIPERFECT DAY1286 mg/51.45g58411-351
- cle de peau BEAUTE SYNACTIF DAYTIME MOISTURIZER ENRICHED n (Refill)5 mg/200mL58411-890
- Daily Defence Shield SPF 3014 mg/g65912-003
- SHISEIDO WHITE LUCENT DAY1.285 g/50mL58411-463
- SHISEIDO BENEFIANCE WRINKLERESIST24 DAY1.28 g/50mL58411-629
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)